Jun 14, 2021 / 03:30PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
(technical difficulty) and wish that next year, it will be in person. But it is what it is. We're thrilled to have in the very first session for today, BioXcel Therapeutics. And sitting with us here is CEO, Vimal Mehta; and we also have Will Kane, who is Head of Commercial. Guys, welcome.
Vimal D. Mehta - BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director
Thank you, Geoff.
William P. Kane - BioXcel Therapeutics, Inc. - Executive VP & Chief Commercial Officer
Welcome, Geoff.
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
All right. So we'll kick it off with just anything that you guys wanted to start off with prepared remark wise, we have a lot of questions here. We have some questions from investors as well. So, Vimal, over to you.
Vimal D. Mehta - BioXcel Therapeutics, Inc. - Founder, CEO, President,
BioXcel Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript
Mar 03, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers